Skip to content

Medical-device intelligence

Roche Molecular Systems Inc: FDA clearances and recalls

Research Roche Molecular Systems Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

52 clearance records and 66 recall records in the covered releases, across 1 source company names and 37 product codes. Dated history runs from Jun 15, 1993 to Aug 28, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202530
December 202500
January 202600
February 202600
March 202600
April 202600
May 202620
June 202600
July 202620
August 202620
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

118 matching records
Device / recordCompany in FDA recordSourceSource date
cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative Control Kit for use on the co…K260045 · OZNRoche Molecular Systems, Inc.510(k)Aug 28, 2026FDA decision date
cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas Strep A Quality Control Kit (07402678190)K260047 · PGXRoche Molecular Systems, Inc.510(k)Aug 28, 2026FDA decision date
cobas® BV/CVK260021 · PQARoche Molecular Systems, Inc.510(k)Jul 16, 2026FDA decision date
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systemsK260917 · QEPRoche Molecular Systems, Inc.510(k)Jul 8, 2026FDA decision date
cobas liat CT/NG nucleic acid testK253756 · QEPRoche Molecular Systems, Inc.510(k)May 15, 2026FDA decision date
cobas liat CT/NG/MG nucleic acid testK253759 · QEPRoche Molecular Systems, Inc.510(k)May 15, 2026FDA decision date
cobas liat Bordetella panel nucleic acid testK243753 · OZZRoche Molecular Systems, Inc.510(k)Nov 20, 2025FDA decision date
cobas CMVK252481 · PABRoche Molecular Systems, Inc.510(k)Nov 3, 2025FDA decision date
cobas HCVK252484 · MZPRoche Molecular Systems, Inc.510(k)Nov 3, 2025FDA decision date
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 SystemsK243455 · QOFRoche Molecular Systems, Inc.510(k)Jul 31, 2025FDA decision date
Opulus™ Lymphoma PrecisionK243863 · QIHRoche Molecular Systems, Inc.510(k)May 30, 2025FDA decision date
cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid testK243400 · QOFRoche Molecular Systems, Inc.510(k)Apr 25, 2025FDA decision date
cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid testK243406 · QOFRoche Molecular Systems, Inc.510(k)Apr 25, 2025FDA decision date
cobas liat SARS-CoV-2 v2 nucleic acid testK243346 · QWRRoche Molecular Systems, Inc.510(k)Apr 11, 2025FDA decision date
cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 SystemsK240867 · QQXRoche Molecular Systems, Inc.510(k)Feb 11, 2025FDA decision date
cobas® liat CT/NG nucleic acid testK240217 · QEPRoche Molecular Systems, Inc.510(k)Jan 17, 2025FDA decision date
cobas® liat CT/NG/MG nucleic acid testK240197 · QEPRoche Molecular Systems, Inc.510(k)Jan 16, 2025FDA decision date
cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat SystemK223783 · QWRRoche Molecular Systems, Inc.510(k)Dec 4, 2023FDA decision date
cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® SystemK223591 · QOFRoche Molecular Systems, Inc.510(k)Jul 27, 2023FDA decision date
cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 SystemsK231306 · QQXRoche Molecular Systems, Inc.510(k)Jun 1, 2023FDA decision date
cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190Z-1104-2023 · QLTRoche Molecular Systems, Inc.RecallFeb 7, 2023FDA classification date
cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190Z-1105-2023 · QLTRoche Molecular Systems, Inc.RecallFeb 7, 2023FDA classification date
cobas Influenza A/B & RSV UC (Utility Channel) Qualitative nucleic acid test for use on the cobas 6800/8800 Systems; Material number 09233962190Z-1106-2023 · QLTRoche Molecular Systems, Inc.RecallFeb 7, 2023FDA classification date
cobas HCVK221007 · MZPRoche Molecular Systems, Inc.510(k)Nov 4, 2022FDA decision date
cobas SARS-CoV-2 Qualitative for use on the cobas 6800/8800 SystemsK213804 · QQXRoche Molecular Systems, Inc.510(k)Oct 22, 2022FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗